China NMPA Drug Inspection - 17 companies including Hebei Kangyiqiang Pharmaceutical Co., Ltd. - 19 batches of Chinese herbal medicine slices
China NMPA drug inspection for 17 companies including Hebei Kangyiqiang Pharmaceutical Co., Ltd. published November 18, 2019. Drug: 19 batches of Chinese herbal medicine slices. The Shandong Provincial Food and Drug Administration, under the National Medical Products Administration (NMPA), issued
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for 17 companies including Hebei Kangyiqiang Pharmaceutical Co., Ltd. published November 18, 2019. Drug: 19 batches of Chinese herbal medicine slices. The Shandong Provincial Food and Drug Administration, under the National Medical Products Administration (NMPA), issued
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox